Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Stanford University
University of California, Davis
Hoffmann-La Roche
University of Florida
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Guerbet
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Circle Pharma
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Taproot Health
Rigshospitalet, Denmark
Hoffmann-La Roche
Vanderbilt-Ingram Cancer Center
University of California, San Francisco
Stanford University
Merck Sharp & Dohme LLC